Joanna Dewar - Concepedia

Author

Joanna Dewar

Sir Charles Gairdner Hospital ORCID

Also Known As

J Dewar, J M Dewar, J. Dewar, J. M. Dewar, JOANNA M. DEWAR, Joanna Dewar, Joanna M Dewar, Joanna M. Dewar

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Sir Charles Gairdner Hospital The University of Western Australia Mount Medical Centre Peter MacCallum Cancer Centre Institut Jules Bordet

About

Joanna Dewar is an author at Sir Charles Gairdner Hospital specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	714
2	Health Sciences	2	2	192
3	Public Health	2	2	27
4	Nursing	1	1	33
5	Hepatology	1	1	15

Joanna Dewar

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer Charles E. Geyer, Judy E. Garber, Richard D. Gelber, Annals of Oncology Breast OncologyOverall SurvivalMedicinePathologyGermline Pathogenic Variants	2022	404
Cisplatin and Gemcitabine Treatment for Malignant Mesothelioma: A Phase II Study Michael Byrne, Jennifer Davidson, Arthur W. Musk, Journal of Clinical Oncology	1999	335
Impact of multidisciplinary team management in head and neck cancer patients Peter Friedland, Biljana Božić, Joanna Dewar, British Journal of Cancer	2011	218
Initial Paclitaxel Improves Outcome Compared With CMFP Combination Chemotherapy as Front-Line Therapy in Untreated Metastatic Breast Cancer James F. Bishop, Joanna Dewar, Guy C. Toner, Journal of Clinical Oncology	1999	211
The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial Evandro de Azambuja, Worta McCaskill‐Stevens, Prudence A. Francis, Breast Cancer Research and Treatment Big 02-98Breast OncologyOncologyBody Mass IndexClinical Trials	2009	159
Cisplatin neuropathy with Lhermitte's sign. Joanna Dewar, Helen Lunt, David Abernethy, Journal of Neurology Neurosurgery & Psychiatry	1986	45
Paclitaxel as first-line treatment for metastatic breast cancer. The Taxol Investigational Trials Group, Australia and New Zealand. James F. Bishop, Joanna Dewar, Guy C. Toner, PubMed Metastatic Breast CancerCmfp Combination TherapyPaclitaxel TreatmentBreast OncologyMedicine	1997	33
BREAST CANCER IN WESTERN AUSTRALIA IN 1989. II. DIAGNOSIS AND PRIMARY MANAGEMENT Michael Byrne, Konrad Jamrozik, Richard Parsons, Australian and New Zealand Journal of Surgery NursingSurgical OncologyWestern AustraliaPrimary ManagementBreast Oncology	1993	33
Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials Group. Michael Byrne, Val Gebski, John Forbes, Journal of Clinical Oncology	1997	27
Breast cancer in Western Australia: clinical practice and clinical guidelines Suzanne McEvoy, Claire M. A. Haworth, Jennett M Harvey, The Medical Journal of Australia	2004	24

Page 1